Nanotechnology-driven advances in the treatment of diabetic wounds

Biotechnol Appl Biochem. 2021 Dec;68(6):1281-1306. doi: 10.1002/bab.2051. Epub 2020 Oct 19.

Abstract

Diabetic foot ulcers (DFUs) are chronic severe complications of diabetes disease and remain a worldwide clinical challenge with social and economic consequences. Diabetic wounds can cause infection, amputation of lower extremities, and even death. Several factors including impaired angiogenesis, vascular insufficiency, and bacterial infections result in a delayed process of wound healing in diabetic patients. Treatment of wound infections using traditional antibiotics has become a critical status. Thus, finding new therapeutic strategies to manage diabetic wounds is urgently needed. Nanotechnology has emerged as an efficient approach for this purpose. This review aimed to summarize recent advances using nanotechnology for the treatment of diabetic wounds.

Keywords: diabetes; diabetic foot ulcer; nanomaterials; nanotechnology; ulcer; wound.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Diabetes Mellitus / drug therapy*
  • Diabetic Foot / drug therapy*
  • Humans
  • Nanotechnology*
  • Wound Healing / drug effects*

Substances

  • Anti-Bacterial Agents